NRS
GEHC icon

Neville Rodie & Shaw’s GE HealthCare GEHC Stock Holding History

Neville Rodie & Shaw’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,600
Closed -$210K – 250
2025
Q1 		$210K Hold
2,600
– – 0.02% 236
2024
Q4 		$203K Hold
2,600
– – 0.01% 249
2024
Q3 		$244K Sell
2,600
-478
-16% -$40.1K 0.02% 225
2024
Q2 		$240K Buy
3,078
+205
+7% +$16.7K 0.02% 222
2024
Q1 		$261K Sell
2,873
-877
-23% -$73K 0.02% 226
2023
Q4 		$290K Sell
3,750
-16
-0.4% -$1.12K 0.02% 216
2023
Q3 		$257K Sell
3,766
-40
-1% -$2.91K 0.02% 220
2023
Q2 		$309K Sell
3,806
-20
-0.5% -$1.6K 0.03% 210
2023
Q1 		$314K Buy
+3,826
New +$273K 0.03% 211

Other funds holding GEHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neville Rodie & Shaw's GEHC Position: Q2 2025 in Review

Neville Rodie & Shaw sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 2,600 shares — an estimated $210K sold.

Neville Rodie & Shaw first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $314K in Q1 2023. 1,316 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Neville Rodie & Shaw reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Neville Rodie & Shaw sold 2,600 GE HealthCare shares in Q2 2025, an estimated $210K.
  • Neville Rodie & Shaw first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Neville Rodie & Shaw's GE HealthCare position peaked at $314K in Q1 2023.
  • 1,316 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Neville Rodie & Shaw's 13F filing for Q2 2025, filed 2 Jul 2025.